Target
Interleukin-17A
Ligand
BDBM419225
Substrate
n/a
Meas. Tech.
I L-17A Secretion
IC50
<100±n/a nM
Citation
 Musicki, BBouix-Peter, COuvry, GThoreau, E Benzenesulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (RORγ(T)) US Patent  US10457637 Publication Date 10/29/2019 
Target
Name:
Interleukin-17A
Synonyms:
CTLA8 | Cytotoxic T-lymphocyte-associated antigen 8 | IL-17 | IL17 | IL17A | IL17_HUMAN | il-17a
Type:
Enzyme Catalytic Domain
Mol. Mass.:
17511.44
Organism:
Homo sapiens (Human)
Description:
Q16552
Residue:
155
Sequence:
MTPGKTSLVSLLLLLSLEAIVKAGITIPRNPGCPNSEDKNFPRTVMVNLNIHNRNTNTNPKRSSDYYNRSTSPWNLHRNEDPERYPSVIWEAKCRHLGCINADGNVDYHMNSVPIQQEILVLRREPPHCPNSFRLEKILVSVGCTCVTPIVHHVA
  
Inhibitor
Name:
BDBM419225
Synonyms:
N-(4-ethylphenyl)-N- isobutyl-3-(S- methylsulfonimidoyl)-4- ((thietan-3- ylmethyl)amino)benzene- sulfonamide | US10457637, Compound 99
Type:
Small organic molecule
Emp. Form.:
C23H33N3O3S3
Mol. Mass.:
495.721
SMILES:
CCc1ccc(cc1)N(CC(C)C)S(=O)(=O)c1ccc(NCC2CSC2)c(c1)S(C)(=N)=O
Structure:
Search PDB for entries with ligand similarity: